Evidence map›Paper›PMID 17130488›Full record

ArticleDiabetes2006

OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization.

Nathan E Wolins, Benjamin K Quaynor, James R Skinner, Anatoly Tzekov, Michelle A Croce, Matthew C Gropler, Vijayalakshmi Varma, Aiwei Yao-Borengasser, Neda Rasouli, Philip A Kern and 2 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Diabetes, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT00108615. Cited by 177 papers.

0numbers the graph read from it
0cells of the map it votes in
177citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00108615 phase4completed

Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance

Ran2004Enrolled48Registered outcomes2Posted comparisons0ConditionsDiabetes, Glucose Metabolism DisordersArmsCT scans, Metformin, Oral glucose tolerance test, Pioglitazone
Open the trial in the graph
3 · Its place in the literature

Who cites it

177 citing papers in PubMed, 325 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Biomarkers of Cardiovascular Stress: A Historical Review.Journal of cardiovascular development and disease · 2026
    Review
  6. Article
  7. Article
  8. Biology · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

117 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Nathan E WolinsDepartment of Medicine, 660 S. Euclid Ave., Campus Box 8127, St. Louis, MO 63110, USA.
Benjamin K Quaynor
James R Skinner
Anatoly Tzekov
Michelle A Croce
Matthew C Gropler
Vijayalakshmi Varma
Aiwei Yao-Borengasser
Neda Rasouli
Philip A Kern
Brian N Finck
Perry E Bickel
Washington University in St. Louis · USUniversity of Arkansas for Medical Sciences · USCentral Arkansas Veterans Healthcare System · US

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
Verruca Vulgaris--Skin Test &Candida /Mumps AntigenM01RR014288 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI PONNAPPAN, USHA · 1999 to 2006
$11.1M
CELL BIOLOGIC APPROACHES TO DIABETES RESEARCHT32DK007296 · NIDDK · WASHINGTON UNIVERSITY · PI COLONNA, MARCO · 1986 to 2014
$3.3M
Regulation of lipoprotein lipase in adipocytesR37DK039176 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI KERN, PHILIP A · 2006 to 2011
$1.8M
REGULATION OF LIPOPROTEIN LIPASE IN HUMAN ADIPOCYTESR01DK039176 · NIDDK · UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK · PI KERN, PHILIP A · 1993 to 2005
$1.6M
Mechanisms underlying metabolic syndrome in obesityR01DK071277 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI KERN, PHILIP A · 2005 to 2008
$848k
Trafficking of Triacylglycerol in AdipocytesR01DK068046 · NIDDK · WASHINGTON UNIVERSITY · PI BICKEL, PERRY E · 2005 to 2007
$776k
Regulation of glucose transporter expression by PPARaK01DK062903 · NIDDK · WASHINGTON UNIVERSITY · PI FINCK, BRIAN N · 2003 to 2005
$260k
REGULATION OF LIPOPROTEIN LIPASE IN HUMAN ADIPOCYTESR29DK039176 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI KERN, PHILIP A · 1988 to 1990
–
NCRR NIH HHS M01 RR14288NIDDK NIH HHS DK39176NIDDK NIH HHS DK71277NIDDK NIH HHS K01 DK062903NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30 DK52574NIDDK NIH HHS R01 DK068046NIDDK NIH HHS T32 DK07296
6 · The paper itself

Abstract

Lipid droplet proteins of the PAT (perilipin, adipophilin, and TIP47) family regulate cellular neutral lipid stores. We have studied a new member of this family, PAT-1, and found that it is expressed in highly oxidative tissues. We refer to this protein as "OXPAT." Physiologic lipid loading of mouse liver by fasting enriches OXPAT in the lipid droplet tissue fraction. OXPAT resides on lipid droplets with the PAT protein adipophilin in primary cardiomyocytes. Ectopic expression of OXPAT promotes fatty acid-induced triacylglycerol accumulation, long-chain fatty acid oxidation, and mRNAs associated with oxidative metabolism. Consistent with these observations, OXPAT is induced in mouse adipose tissue, striated muscle, and liver by physiological (fasting), pathophysiological (insulin deficiency), pharmacological (peroxisome proliferator-activated receptor [PPAR] agonists), and genetic (muscle-specific PPARalpha overexpression) perturbations that increase fatty acid utilization. In humans with impaired glucose tolerance, PPARgamma agonist treatment induces adipose OXPAT mRNA. Further, adipose OXPAT mRNA negatively correlates with BMI in nondiabetic humans. Our collective data in cells, mice, and humans suggest that OXPAT is a marker for PPAR activation and fatty acid oxidation. OXPAT likely contributes to adaptive responses to the fatty acid burden that accompanies fasting, insulin deficiency, and overnutrition, responses that are defective in obesity and type 2 diabetes.

Indexed as

Amino Acid SequenceAnimalsBase SequenceBlotting, NorthernCell LineDNA PrimersFatty AcidsGenomeIntracellular Signaling Peptides and ProteinsLiverMaleMiceMice, Inbred C57BLMolecular Sequence DataMuscle CellsMyocardiumDNA PrimersFatty AcidsIntracellular Signaling Peptides and ProteinsOXPAT protein, mousePalmitic AcidPeptide FragmentsPeroxisome Proliferator-Activated Receptors

Identifiers

PMID17130488
OpenAlexW2159758687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.